The superiority of bivalent over monovalent booster vaccines

Ronen Arbel; Yael Wolff-Sagy

doi:10.1016/S1473-3099(23)00424-3

The superiority of bivalent over monovalent booster vaccines

Ronen Arbel
, Yael Wolff-Sagy

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	1324-1325
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	23
Issue number	12
DOIs	https://doi.org/10.1016/S1473-3099(23)00424-3
State	Published - 1 Dec 2023
Externally published	Yes

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1016/S1473-3099(23)00424-3

Cite this

@article{9d2aa0d6b77e44b0bd023bcbf65e24fc,

title = "The superiority of bivalent over monovalent booster vaccines",

author = "Ronen Arbel and Yael Wolff-Sagy",

year = "2023",

month = dec,

day = "1",

doi = "10.1016/S1473-3099(23)00424-3",

language = "English",

volume = "23",

pages = "1324--1325",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "12",

}

TY - JOUR

T1 - The superiority of bivalent over monovalent booster vaccines

AU - Arbel, Ronen

AU - Wolff-Sagy, Yael

PY - 2023/12/1

Y1 - 2023/12/1

UR - https://www.scopus.com/pages/publications/85169036101

U2 - 10.1016/S1473-3099(23)00424-3

DO - 10.1016/S1473-3099(23)00424-3

M3 - Comment/debate

C2 - 37543043

AN - SCOPUS:85169036101

SN - 1473-3099

VL - 23

SP - 1324

EP - 1325

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 12

ER -

The superiority of bivalent over monovalent booster vaccines

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this